VivoMetrics
This article was originally published in The Gray Sheet
Executive Summary
Second $5 mil. installment of total $10 mil. Series A financing from Credit Suisse First Boston, Cyberfund and Hammer Capital is triggered by initial scale-up of the LifeShirt ambulatory monitoring system. The device, which continuously collects respiratory and heart rate data, blood-oxygen saturation levels, ECG waveform and systolic and diastolic heart function measures, will now be clinically evaluated in preparation for a 510(k) submission, Ventura, California-based VivoMetrics reports